Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8758241 | European Journal of Internal Medicine | 2017 | 5 Pages |
Abstract
An important caveat of future devices is to assess their effect in relevant patient populations and not only in healthy test-subjects. Implementation of novel technologies is expensive although expected to be cost-effective if just few adverse events can be prevented. The future is here with promising devices and the possibility to give an unprecedented precise risk estimation of adverse post-surgical events. Next step is to integrate existing evidence based treatment algorithms to demonstrate the clinical efficacy of implementing the new technology.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
C. Haahr-Raunkjær, C.S. Meyhoff, H.B.D. Sørensen, R.M. Olsen, E.K. Aasvang,